EIRL - NEXT MEDICAL VISION EIRL - NEXT MEDICAL VISION

JA Download Free Trial

Product

EIRL’s product lineup

EIRL Brain Aneurysm

Brain aneurysm detection support technology advanced from MRA

EIRL Brain Metry

Diagnostic support for detecting brain aneurysms from brain MRA

EIRL Chest Nodule

Chest nodule detection support technology that makes an effective diagnosis possible

Download Free Trial

Research and Development
LPIXEL puts focus on a various array of
diseases to optimize doctor’s workloads.

EIRL’s goals are to serve as an aid to sustainable development for medical and to maximize people’s well-being. LPIXEL puts focus on developing medical image diagnosis support technology with our distinctive algorithm powered by AI, leveraging a numerous amount of medical big data which revolves around medical images such as CTs, MRIs, and pathological images.

The following software under research and development has not yet been granted an approval under the Pharmaceutical Affairs Act. Hence, this can be used for neither medical use nor single application but can be used for situations such as researches, examinations, and education that don’t have any ill effect on a human body, and the explanation for research subjects.

Powered by a spirit of venture and a cutting-edge technology, LPIXEL challenges itself to create the future of medical.

LPIXEL aims to expand its expertise into the world and provide a prosperous future and revolutionary products as a hub for open innovation with its various partners. With this belief in mind, LPIXEL is on a continuous journey to make the world a happier place for everyone.

BRAIN Brain Disease

Brain Intracranial Stenosis Detection

In efforts to reduce the number of misdiagnosed cases of intracranial stenosis, our technology conducts a careful analysis of MRA scans to detect patterns that are similar to narrowed arteries.

LUNG Lung Disease

Lung Cancer

This cutting edge technology targets lung cancer CT scans to automatically identify the type of lung cancer and gene mutation. Our goal is to reduce the need for highly invasive biopsies and open doors to imaging-based treatment options for patients.


*Currently under development with the National Cancer Center in Japan.

BREAST Mammary Gland Disease

Breast Cancer

This technology conducts a time-intensity curve (TIC) analysis for MRI scans of the breasts. Our goal is to be able to augment machine learning technology to identify the degree of malignancy of the tumor.

LUNG Colonic Disease

Colon Cancer

With aims to decrease the number of overlooked lesions, this technology analyzes the examination results of the colonoscopy images in real time and displays the areas in the colon where the prevalence of lesions, such as tumors, are high.

*Image provided by The Jikei University School of Medicine

Awards

Awards in and outside of Japan

  • AWARD 01

    2017 Red Herring
    Global Top 100

  • AWARD 02

    SLINGSHOT@SWITCH 2017
    Runners-up Award

  • AWARD 03

    Japan Healthcare Business
    Contest 2017 Excellence Award

Partners

LPIXEL is enhancing active joint research and development collaborations for EIRL with various parners.

  • JOINT RESEARCH 01

    National Cancer Center Japan

  • JOINT RESEARCH 02

    Osaka City University

  • JOINT RESEARCH 03

    The Jikei University

  • JOINT RESEARCH 04

    The University of Tokyo Hospital

Publications
and Conference information

Conference information

2018.11.29

Deep Learning based Computer-Aided Detection of Unruptured Cerebral Aneurysms

2018.06.02

The Detection and Differential Diagnosis of Colonic Lesions with an Artificial Intelligence Algorithm

2018.04.13

Deep Learning for MR Angiography: Automated Detection of Cerebral Aneurysms